Quantitative analysis of the impact of total ischemic time on myocardial perfusion and clinical outcome in patients with ST-elevation myocardial infarction

American Journal of Cardiology

Volumn 108, Issue 11, 2011, Pages 1536-1541

  Fokkema, Marieke L ^a   Wieringa, Wouter G ^a   Van Der Horst, Iwan C ^a   Boersma, Eric ^b   Zijlstra, Felix ^b   De Smet, Bart J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN;

ADULT; AGED; ARTICLE; BALLOON CATHETER; BLOOD CLOT LYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENDER; HEART INFARCTION SIZE; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; ISCHEMIC PRECONDITIONING; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDIAL ISCHEMIA TIME; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX RATIO; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS ASPIRATION; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; SUCTION; THROMBECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 80955163655     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.07.010     Document Type: Article

References (29)

1. K.A. Reimer, J.E. Lowe, M.M. Rasmussen, and R.B. Jennings The wavefront phenomenon of ischemic cell death 1. Myocardial infarct size vs duration of coronary occlusion in dogs Circulation 56 1977 786 794
2. M. Francone, C. Bucciarelli-Ducci, I. Carbone, E. Canali, R. Scardala, F.A. Calabrese, G. Sardella, M. Mancone, C. Catalano, F. Fedele, R. Passariello, J. Bogaert, and L. Agati Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 2145 2153
3. G. Tarantini, L. Cacciavillani, F. Corbetti, A. Ramondo, M.P. Marra, M. Bacchiega E Napodano, C. Bilato, R. Razzolini, and S. Iliceto Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance J Am Coll Cardiol 46 2005 1229 1235
4. B.R. Brodie, T.D. Stuckey, T.C. Wall, G. Kissling, C.J. Hansen, D.B. Muncy, R.A. Weintraub, and T.A. Kelly Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction J Am Coll Cardiol 32 1998 1312 1319
5. B.R. Brodie, J. Webb, D.A. Cox, M. Qureshi, A. Kalynych, M. Turco, H.P. Schultheiss, D. Dulas, B. Rutherford, D. Antoniucci, T. Stuckey, M. Krucoff, R. Gibbons, A. Lansky, Y. Na, R. Mehran, and G.W. Stone Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD trial) Am J Cardiol 99 2007 1680 1686
6. G. De Luca, H. Suryapranata, G.W. Stone, D. Antoniucci, J.E. Tcheng, F.J. Neumann, F. Van de Werf, E.M. Antman, and E.J. Topol Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
7. G. Montalescot, P. Barragan, O. Wittenberg, P. Ecollan, S. Elhadad, P. Villain, J.M. Boulenc, M.C. Morice, L. Maillard, M. Pansiéri, R. Choussat, and P. Pinton Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903
8. D. Antoniucci, A. Rodriguez, A. Hempel, R. Valenti, A. Migliorini, F. Vigo, G. Parodi, C. Fernandez-Pereira, G. Moschi, A. Bartorelli, G.M. Santoro, L. Bolognese, and A. Colombo A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction J Am Coll Cardiol 42 2003 1879 1885
9. T. Svilaas, P.J. Vlaar, I.C. van der Horst, G.F. Diercks, B.J. de Smet, A.F. van den Heuvel, R.L. Anthonio, G.A. Jessurun, E.S. Tan, A.J. Suurmeijer, and F. Zijlstra Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567
10. G. De Luca, D. Dudek, G. Sardella, P. Marino, B. Chevalier, and F. Zijlstra Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials Eur Heart J 29 2008 3002 3010
11. S. Silber, P. Albertsson, F.F. Avilés, P.G. Camici, A. Colombo, C. Hamm, E. Jørgensen, J. Marco, J.E. Nordrehaug, W. Ruzyllo, P. Urban, G.W. Stone, W. Wijns The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Guidelines for percutaneous coronary interventions Eur Heart J 26 2005 804 847
12. TIMI Study Group The Thrombolysis In Myocardial Infarction (TIMI) trial Phase I findings N Engl J Med 312 1985 932 936
13. T.A. Mabin, D.R. Holmes Jr, H.C. Smith, R.E. Vlietstra, A.A. Bove, G.S. Reeder, J.H. Chesebro, J.F. Bresnahan, and T.A. Orszulak Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty J Am Coll Cardiol 5 1985 198 202
14. J.P. Henriques, F. Zijlstra, J.P. Ottervanger, M.J. de Boer, A.W. van 't Hof, J.C. Hoorntje, and H. Suryapranata Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction Eur Heart J 23 2002 1112-1117
15. A.W. van 't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, F. Zijlstra Zwolle Myocardial Infarction Study Group Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Circulation 97 1998 2302 2306
16. A.W. van 't Hof, A. Liem, M.J. de Boer, F. Zijlstra Zwolle Myocardial Infarction Study Group Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction Lancet 350 1997 615 619
17. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
18. G. De Luca, H. Suryapranata, F. Zijlstra, A.W. van 't Hof, J.C. Hoorntje, A.T. Gosselink, J.H. Dambrink, and M.J. de Boer Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty J Am Coll Cardiol 42 2003 991 997
19. G. De Luca, A.W. van 't Hof, M.J. de Boer, J.P. Ottervanger, J.C. Hoorntje, A.T. Gosselink, J.H. Dambrink, F. Zijlstra, and H. Suryapranata Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty Eur Heart J 25 2004 1009 1013
20. E. Boersma, A.C. Maas, J.W. Deckers, and M.L. Simoons Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour Lancet 348 1996 771 775
21. E. Boersma Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients Eur Heart J 27 2006 779 788
22. M. Gierlotka, M. Gasior, K. Wilczek, M. Hawranek, J. Szkodzinski, P. Paczek, A. Lekston, Z. Kalarus, M. Zembala, and L. Polonski Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]) Am J Cardiol 107 2011 501 508
23. P.J. Vlaar, T. Svilaas, K. Damman, B.J. de Smet, J.G. Tijssen, H.L. Hillege, and F. Zijlstra Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review Circulation 118 2008 1828 1836
24. E. Falk, and L. Thuesen Pathology of coronary microembolisation and no reflow Heart 89 2003 983 985
25. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
26. M. Sejersten, S.L. Nielsen, T. Engstrøm, E. Jørgensen, and P. Clemmensen Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction Am J Cardiol 103 2009 1635 1640
27. U. Zeymer, A. Margenet, M. Haude, C. Bode, J.M. Lablanche, H. Heuer, R. Schröder, S. Kropff, R. Bourkaib, N. Banik, R. Zahn, and E. Teiger Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI trial J Am Coll Cardiol 56 2010 463 469
28. G. Montalescot, S.D. Wiviott, E. Braunwald, S.A. Murphy, C.M. Gibson, C.H. McCabe, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
29. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, A. Freij, M. Thorsén PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057